Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab

ConclusionsThe development of irAEs might be associated with survival outcomes with nivolumab treatment in patients with  AGC.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research